BeiGene, Ltd. Files 8-K for Material Agreement

TL;DR

BeiGene just signed a big deal, creating a new financial obligation. Watch this space.

AI Summary

On December 9, 2024, BeiGene, Ltd. entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. The filing includes financial statements and exhibits related to these events.

Why It Matters

This 8-K filing signals a significant new financial commitment or obligation for BeiGene, Ltd., which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Material definitive agreements and new financial obligations can introduce financial risks and operational changes that warrant close monitoring.

Key Players & Entities

• BeiGene, Ltd. (company) — Registrant
• December 9, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.0001 — resenting 13 Ordinary Shares, par value $0.0001 per share BGNE The NASDAQ Global Sele
• $400 million — . The Facility Agreement provides for a $400 million uncommitted and unsecured credit facili
• $380 million — the date hereof, the Company has drawn $380 million from the Existing Credit Facility and p
• $300 million — ting Credit Facility and plans to repay $300 million of the Existing Credit Facility in Dece
• $80 million — 24, reducing the outstanding balance to $80 million which the Company plans to repay fully

Filing Documents

• bgne-20241209.htm (8-K) — 39KB
• a20241210formxcmbloanxex10.htm (EX-10.1) — 247KB
• 0001651308-24-000164.txt ( ) — 454KB
• bgne-20241209.xsd (EX-101.SCH) — 2KB
• bgne-20241209_lab.xml (EX-101.LAB) — 21KB
• bgne-20241209_pre.xml (EX-101.PRE) — 12KB
• bgne-20241209_htm.xml (XML) — 3KB

01. Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement. On December 9, 2024 (the "Signing Date"), a facility agreement (the "Facility Agreement") was entered into by and between BeiGene, Ltd. (the "Company"), as the borrower, and China Merchants Bank Co., Ltd., as the lender (the "Lender"). The Facility Agreement provides for a $400 million uncommitted and unsecured credit facility (the "Credit Facility"), pursuant to which each loan issued has a term up to one year, provided that all loans must be repaid within 18 months of the Signing Date. Loans under the Credit Facility have a floating interest rate based on the secured overnight financing rate plus an applicable margin and are calculated daily from the date the loan is utilized and settled on a quarterly basis. The proceeds of the loans under the Credit Facility are available for daily operations of the Company and its subsidiaries and for refinancing of the Company's working capital loans with other banks. The Facility Agreement contains financial covenants that require the Company to uphold a certain ratio of liabilities to ownership equity and maintain specified amounts of both consolidated net assets and consolidated cash balance, all of which are tested quarterly. The Facility Agreement also contains operating covenants including, among other things, (i) maintaining its listing status on The Stock Exchange of Hong Kong Limited and The Science and Technology Innovation Board of the Shanghai Stock Exchange, (ii) maintaining the amount of interest payable on the outstanding principal for two quarters in an account with the Lender, (iii) limitations on the incurrence of certain additional indebtedness to the extent such indebtedness has material adverse effects on the Company's ability to perform its obligations under the Facility Agreement, and (iv) preservation of ownership of key patents and other covenants surrounding the Company's intellectual property. Other certain covenants, representations and warran

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 10.1 Facility Agreement, dated as of December 9, 2024, by and between the Company and China Merchants Bank Co., Ltd. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL Exhibit Index Exhibit No. Description 10.1 Facility Agreement, dated as of December 9, 2024, by and between the Company and China Merchants Bank Co., Ltd. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEIGENE, LTD. Date: December 10, 2024 By: /s/ Chan Lee Name: Chan Lee Title: Senior Vice President, General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR